ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
J

2022 ASCO Annual Meeting "The Effects of AVM0703 Mobilization of Endogenous γδ Invariant TCR+ Bi-specific NKT-like Cells Against Solid Tumors & Blood Cancers"

By ASCO 2022 Conference Coverage FEATURING Jena Dalpez
By ASCO 2022 Conference Coverage FEATURING Jena Dalpez
118 views
July 1, 2022
Dr. Theresa Deisher of AVM Biotechnology provides an explanation of poster #2579 presented at the ...
read more ↘
Comments 0
Login to view comments. Click here to Login
Lymphoma
04:26

2022 ASCO Annual Meeting "The Effects of AVM0703 Mobilization of End…

ASCO 2022 Conference Coverage

J. Dalpez

118 views
01:07

Lecture Summary - ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequen…

ASCO 2022 Conference Coverage

J. Winter

42 views
09:39

ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequential Pembro & Chem…

ASCO 2022 Conference Coverage

J. Winter

13 views
01:13

Lecture Summary - ASCO 2022 on the Phase III frontMIND Study: Tafasi…

ASCO 2022 Conference Coverage

U. Vitolo

42 views
08:45

ASCO 2022 on the Phase III frontMIND Study: Tafasitamab + Lenalidomi…

ASCO 2022 Conference Coverage

U. Vitolo

23 views
08:55

ASCO 2022 on the Analysis of Peripheral Neuropathy in 1L DLBCL Using…

ASCO 2022 Conference Coverage

M. Trneny

23 views
10:16

ASCO 2022 ADCs and CARs: Racing to Cure Aggresive Lymphoma

ASCO 2022 Conference Coverage

K. Patel

85 views
13:02

ASCO 2022 on the Predictive Value of TGFβ1/TGFBR2 Ratio for Evaluati…

ASCO 2022 Conference Coverage

V. Bandovkina

106 views
11:30

ASCO 2022 Expert Discussion: Current Treatment Approaches in Hemophi…

ASCO 2022 Conference Coverage

J. Bussel, C. Mcguinn

55 views
01:44

Lecture Summary - ASCO 2022 Treatment Patterns and Real-World Effect…

ASCO 2022 Conference Coverage

M. Di

8 views
05:39

ASCO 2022 Treatment Patterns and Real-World Effectiveness of Rituxim…

ASCO 2022 Conference Coverage

M. Di

102 views
05:16

ASCO 2022 Three-Year Follow-Up of Outcomes With KTE-X19 in R/R Mantl…

ASCO 2022 Conference Coverage

M. Wang

92 views
53

Lecture Summary - ASCO 2022 Three-Year Follow-Up of Outcomes With KT…

ASCO 2022 Conference Coverage

M. Wang

33 views
05:40

ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle Cell Lymphoma: Re…

ASCO 2022 Conference Coverage

P. Jain

87 views
57

Lecture Summary - ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle…

ASCO 2022 Conference Coverage

P. Jain

13 views
07:46

ASCO 2022 on the Initial Safety Run-in Results of the Phase III POLA…

ASCO 2022 Conference Coverage

M. Matasar

76 views
03:32

ASCO 2022 Correlates of Common Concerns in Older Cancer Survivors of…

ASCO 2022 Conference Coverage

M. Loh

19 views
52

Lecture Summary - ASCO 2022 Real World Experience of Combined Treatm…

ASCO 2022 Conference Coverage

M. Kalac

18 views
12:56

ASCO 2022 Real World Experience of Combined Treatment With Romidepsi…

ASCO 2022 Conference Coverage

M. Kalac

16 views
01:33

Lecture Summary - ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as …

ASCO 2022 Conference Coverage

J. Abeykoon

102 views
10:06

ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as Primary Therapy fo…

ASCO 2022 Conference Coverage

J. Abeykoon

1.7K views
42

Lecture Summary - ASCO 2022 on Clinical & PROs in a Phase III, Rando…

ASCO 2022 Conference Coverage

J. Westin

24 views
05:27

ASCO 2022 on Clinical & PROs in a Phase III, Randomized, Open-Label …

ASCO 2022 Conference Coverage

J. Westin

58 views
04:35

ASCO 2022 on CRC-403: A Phase 1/2 Study of bbT369, A Dual Targeting …

ASCO 2022 Conference Coverage

F. Locke

52 views
34

Lecture Summary - ASCO 2022 Updated Interim Analysis of the Randomiz…

ASCO 2022 Conference Coverage

C. Lee Batlevi

19 views
05:16

ASCO 2022 Updated Interim Analysis of the Randomized Phase 1b/3 Stud…

ASCO 2022 Conference Coverage

C. Lee Batlevi

64 views
05:13

ASCO 2022 PACIFIC Trial Updates: Response Kinetics, Safety & Efficac…

ASCO 2022 Conference Coverage

R. Steiner

413 views